Advertisement

Topics

Latest "ETF Managers Group" News Stories

16:46 EST 21st January 2019 | BioPortfolio

Here are the most relevant search results for "ETF Managers Group" found in our extensive news archives from over 250 global news sources.

More Information about ETF Managers Group on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ETF Managers Group for you to read. Along with our medical data and news we also list ETF Managers Group Clinical Trials, which are updated daily. BioPortfolio also has a large database of ETF Managers Group Companies for you to search.

Showing "Managers Group" News Articles 1–25 of 7,900+

Monday 21st January 2019

Chongqing Taiji Industry Group Co Ltd 600129 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryChongqing Taiji Industry Group Co Ltd Chongqing Taiji is a provider of generic products. The company offers products such as traditional Chinese medicine, hospital products, OTC products, base products, and dietary supplement. It provides research and development, equipment, and management services. Chongqing Taiji offer its products in the dosage forms of capsules, syrup, oral liquid, lyop...


Taxi for Just Eat CEO as Uber and Deliveroo serve up competition

Some find group’s prospects not worth waiting for, but others see recipe for success

A Committee of Chiropractors Has Been Formed that Helps Doctors of Chiropractic Succeed in Business

ChiroTrust Founder Ben Altadonna has created a committee that allows Doctors of Chiropractic the ability to collaborate on each other's success. DANVILLE, Calif. (PRWEB) January 21, 2019 Chiropractors are taking success into their own hands and eliminating the need for chiropractic consultants, expensive seminars, coaching, webinars, and podcasts. “As far as I know, in Chiropractic it’s ...


Proteus Digital Health® Founder to Present at World Economic Forum in Davos

Proteus Digital Health® announced today that Andrew Thompson, its President, Chief Executive Officer and Co-Founder, will present on the progress of Proteus’ digital medicines to improve patient treatment and outcomes at the 2019 World Economic Forum Annual Meeting in Davos-Klosters, Switzerland. Mr. Thompson will present on the official progra...

Makers of Malboro Fund Lexaria’s Oral Nicotine Project

In a recent announcement, Malboro cigarette makers Altria Group Inc. (NYSE:MO) have entered into an agreement to fund R&D of Lexaria Bioscience's (CSE:LXX,OTCQX:LXRP) DehydraTECH™technology.  The post Makers of Malboro Fund Lexaria’s Oral Nicotine Project appeared first on Investing News Network.

Almac expanding personalized cancer vaccine production facilities

The Almac Group is doubling its Edinburgh-based footprint to help meet the growing demand for personalized cancer vaccines production.

Arrow Worms Find New Home on Tree of Life

ArticleResearchers have revealed where arrow worms belong on the Tree of Life: they are actually part of a new sister group to the spiralian clade.Staff A

CURE® to Host First-Ever Patient-Focused Session at the 36th Annual Miami Breast Cancer Conference®

The full-day event seeks to educate and inform breast cancer patients and challenge their thinking about the disease CURE Media Group, which reaches over 1 million patients, survivors and caregivers across an industry-leading multichannel platform devoted solely to cancer updates, research and education, will host a patient-track meeting on Saturday, M...

Avacta Group trading in line in "year of very significant progress"

An update on the collaboration with Moderna is planned for the first half of this year.

Alphabet's smart watch ECG gets FDA backing

Alphabet’s life science subsidiary Verily is the latest firm to get an electrocardiogram (ECG) watch approved by the FDA. The FDA approval for the watch’s ECG function intensifies competition with a group of other smart watch manufacturers – the A...

Eckert & Ziegler 2018: Revenue and earnings higher than expected

Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Annual Results Eckert & Ziegler 2018: Revenue and earnings higher than expected 21-Jan-2019 / 12:44 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ...

Hardman & Co Research: Advanced Oncotherapy (AVO): Important regulatory milestone: ISO approval

Hardman & Co Research 21-Jan-2019 / 11:15 GMT/BST Hardman & Co: Important regulatory milestone: ISO approval AVO's goal is to deliver an affordable and novel proton therapy (PT) system, based on state-of-the-art technology developed originally at the CERN. Achievement of major technical milestones has boosted confidence, and the group remains on track with its strategy. AVO has integ...

MinervaX Announces Award of 4.4 Million Euro in Investment from Novo Holdings REPAIR Impact Fund and Sunstone Capital for Further Clinical Development of the Company’s Vaccine Against Group B Streptococcus (GBS)

Copenhagen, Denmark, January 21, 2019 / B3C newswire / -- MinervaX, a privately held Danish biotech company, announces today that is has been awarded an investment of 3.6 mEUR from the Novo Holdings REPAIR Impact Fund for development of therapies to combat antimicrobial resistance (AMR). An additional investment of 0.8 mEUR was obtained from SunStone Capital. The funding will be used to help fina...

Secret to sepsis may lie in rare cell

Scientists reveal how a rare group of white blood cells called basophils play an important role in the immune response to a bacterial infection, preventing the development of sepsis. Researchers say their findings could lead to better ways to prevent the dangerous immune response that strikes more than 30 million people worldwide every year.

France holds trial of firms accused of selling horse meat as beef

Two former managers of French meat-processing firm Spanghero and two Dutch meat traders go on trial in Paris on Monday accused of passing off cheap horse meat as pricier beef in ready-made meals and burgers that were sold in countries across Europe. ...

ProAssurance Corporation Announces Dates for Fourth Quarter 2018 Earnings Release and Conference Call

ProAssurance Corporation (NYSE:PRA) will report results for the year and quarter ended December 31, 2018 after the close of normal New York Stock Exchange trading on Thursday, February 21, 2019. ProAssurance will conduct a conference call at 9:30 AM ET on Friday, February 22, 2019 to discuss the results, and other items of interest to investors pa...

Horizon Discovery extends CRISPR Screening Service to primary human T cells

Extended screening service offers novel capabilities for immuno-oncology research in ex vivo T lymphocytes Service expansion parallels requirements of immunology-based research in drug discovery Cambridge, UK, 21 January, 2019: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies...

Sinochem Completes Elix Purchase

Private equity group Sun European Partners has completed the sale of Elix Polymers to China’s chemical giant Sinochem International for an enterprise value of €195 million.

Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Advanced Hepatocellular Carcinoma in Frontiers in Oncology

Press Release 21 January 2019 Immunicum AB (publ) Announces Publication of Phase  I/II Clinical Trial Results of Ilixadencel in Advanced Hepatocellular Carcinoma in Frontiers in Oncology Immunicum AB (publ; IMMU.ST) announced today that the final data analysis from the exploratory clinical study of ilixadencel in patients with advanced hepatocellular carcinoma (HCC) has been pub...

Microbial Discovery Group Kicks Off 2019 with a New Product Line for the Industrial and Institutional Cleaning Market

Backed by sound science and research with two-day shipping and packaging capabilities, Microbial Discovery Group helps industrial and institutional suppliers stand out with trusted microbial products. FRANKLIN, Wis. (PRWEB) January 21, 2019 Microbial Discovery Group (MDG), a leading Bacillus fermentation company, announced their newest product line, SporActiv™, for the industrial and institutio...

BASF Wins EU Approval for Solvay PA Buy

Following an in-depth investigation into BASF’s proposed purchase of Solvay’s polyamide business, the European Commission has allowed the €1.6 billion transaction to go ahead. In exchange for the green light, the German group agreed to sell assets worth around €450 million.

Sunday 20th January 2019

SanBio: Addition of a Cerebral Hemorrhage Program for SB623 Regenerative Cell Medicine

At a meeting held today, the Board of Directors of SanBio Co., Ltd. (hereinafter, the “Company”) resolved to add a program for treatment of chronic motor deficit from cerebral hemorrhage as a new indication for SB623, a regenerative cell medicine developed by the Group. (Hereinafter, the “Group” refers to two companies, SanBio Co., Ltd., and SanBio...

Rio Ferdinand makes claim about Chelsea players’ WhatsApp group after Arsenal loss – Express.co.uk

Rio Ferdinand makes claim about Chelsea players' WhatsApp group after Arsenal loss Express.co.ukMaurizio Sarri says Chelsea are 'very difficult to motivate' after Arsenal defeat BBC SportArsenal 2-0 Chelsea: Premier League – as it happened The GuardianWATCH: Should Marcos Alonso have seen red for slap on Ainsley Maitland-Niles? SkySportsEPL table, fixtures, results, latest scores and Premier...

Saturday 19th January 2019

Week in Review: Yantai's MabPlex Raises $59 Million to Expand CDMO Services

Deals and Financings  MabPlex, a Yantai biologics CDMO, completed a $59 million Series A round for its biologics development and manufacturing services; Tyto Care, an Israeli telehealth company, raised $9 million from a group that includes China investors for its internet-enabled "home doctor visits"; Ascletis Pharma of Hangzhou acquired China rights to a Suzhou Alphamab anti-PD-L1 candidate...

#VisualAbstract: Randomized Trial of Endoscopic or Open Vein-Graft Harvesting for Coronary-Artery Bypass

1. Among patients randomized to an open or endoscopic vein-graft harvest technique for coronary-artery bypass graft (CABG) surgery, there was no difference in major adverse cardiovascular events (MACE) over a median follow-up of 2.78 years. 2. The rate of leg wound complications was lower in the endoscopic-harvest group compared to the open-harvest group. Evidence Rating […] Source: 2 M...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks